Jama Connect™ and FDA 21 CFR Part 11

For FDA-regulated organizations, compliance is an important goal, but it is not the only factor when delivering safe and reliable products to market. To achieve compliance, organizations need defined processes for development and production and detailed traceability, from the high-level user needs through to validation and verification. Focus and rigor in the product development lifecycle drives compliance as an outcome. Jama Connect eases the path to compliance so companies can focus on building products right. 

In this datasheet, we’ll take a look at FDA 21 CFR Part 11, and detail how Jama Connect helps FDA-regulated companies comply with:  

  • Subpart A – General Provisions  

  • Subpart B – Electronic Records  

  • Subpart C – Electronic Signatures  

Previous Video
Solution: Jama Connect™ for Medical Device Development Overview
Solution: Jama Connect™ for Medical Device Development Overview

Next Flipbook
Jama Connect® for Medical Device Startups Datasheet
Jama Connect® for Medical Device Startups Datasheet

In this datasheet, experts demonstrate how to leverage Jama Connect for Medical Device Startups to accelera...

×

First Name
Last Name
Company
Industry
Country
State
Province
Pending Opt-In
All fields are required. Your privacy is important to us.
Thank you!
Error - something went wrong!